102 related articles for article (PubMed ID: 35098559)
1. Pharmacokinetics of a single dose of oclacitinib maleate as a top dress in adult horses.
Hunyadi L; Datta P; Rewers-Felkins K; Sundman E; Hale T; Fajt V; Wagner S
J Vet Pharmacol Ther; 2022 May; 45(3):320-324. PubMed ID: 35098559
[TBL] [Abstract][Full Text] [Related]
2. A pharmacokinetic study of oclacitinib maleate in six cats.
Ferrer L; Carrasco I; Cristòfol C; Puigdemont A
Vet Dermatol; 2020 Apr; 31(2):134-137. PubMed ID: 31769185
[TBL] [Abstract][Full Text] [Related]
3. The pharmacokinetics of oclacitinib maleate, a Janus kinase inhibitor, in the dog.
Collard WT; Hummel BD; Fielder AF; King VL; Boucher JF; Mullins MA; Malpas PB; Stegemann MR
J Vet Pharmacol Ther; 2014 Jun; 37(3):279-85. PubMed ID: 24330031
[TBL] [Abstract][Full Text] [Related]
4. Acceptance of oclacitinib maleate (Apoquel®) chewable tablets in client-owned dogs with allergic and atopic dermatitis.
Visser M; Walsh K; King V; Sture G; Caneva L
BMC Vet Res; 2022 Mar; 18(1):103. PubMed ID: 35300697
[TBL] [Abstract][Full Text] [Related]
5. Speed of onset of a new chewable formulation of oclacitinib maleate (Apoquel®) in a canine model of IL-31-induced pruritus.
Fleck T; Norris L; King V; Lesman S; Gonzales AJ
J Vet Pharmacol Ther; 2022 Jul; 45(4):380-384. PubMed ID: 35586953
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and plasma protein binding of a single dose of clodronate disodium are similar for juvenile sheep and horses.
Vergara-Hernandez FB; Nielsen BD; Kottwitz JJ; Panek CL; Robison CI; Paris BL; Welsh TH; Bradbery AN; Leatherwood JL; Colbath AC
Am J Vet Res; 2023 Aug; 84(8):. PubMed ID: 37460095
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of oral firocoxib in un-weaned calves.
Wagner SA; Fajt VR; Lo CP; Byrd CJ
J Vet Pharmacol Ther; 2021 Sep; 44(5):793-798. PubMed ID: 33817876
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and pharmacodynamics of oral and intravenous metoprolol tartrate in clinically healthy horses.
Luethy D; Robinson MA; Stefanovski D; Haughan J; Torcivia C; Kowalski A; Ford M; You Y; Missanelli J; Slack J
J Vet Pharmacol Ther; 2022 Mar; 45(2):177-187. PubMed ID: 34913168
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of fluoxetine in horses following oral administration.
Waitt Wolker LH; Veltri CA; Pearman K; Lozoya M; Norris JW
J Vet Pharmacol Ther; 2022 Jan; 45(1):63-68. PubMed ID: 34747024
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulatory effect of long-term oclacitinib maleate therapy in dogs with atopic dermatitis.
De Caro Martins G; da Costa-Val AP; Coura FM; Diamantino GML; Nogueira MM; de Oliveira Melo-Junior OA; Giunchetti RC; da Silveira-Lemos D; Melo MM
Vet Dermatol; 2022 Apr; 33(2):142-e40. PubMed ID: 34747068
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of oclacitinib (Apoquel®) compared with prednisolone for the control of pruritus and clinical signs associated with allergic dermatitis in client-owned dogs in Australia.
Gadeyne C; Little P; King VL; Edwards N; Davis K; Stegemann MR
Vet Dermatol; 2014 Dec; 25(6):512-8, e86. PubMed ID: 25109820
[TBL] [Abstract][Full Text] [Related]
12. Aggression behaviour induced by oral administration of the Janus-kinase inhibitor tofacitinib, but not oclacitinib, under stressful conditions.
Fukuyama T; Tschernig T; Qi Y; Volmer DA; Bäumer W
Eur J Pharmacol; 2015 Oct; 764():278-282. PubMed ID: 26164790
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and physiologic effects of alprazolam after a single oral dose in healthy mares.
Wong DM; Davis JL; Alcott CJ; Hepworth-Warren KL; Galow-Kersh NL; Rice S; Coetzee JF
J Vet Pharmacol Ther; 2015 Jun; 38(3):301-4. PubMed ID: 25427652
[TBL] [Abstract][Full Text] [Related]
14. TREATMENT SUCCESS IN THREE ANDEAN BEARS (TREMARCTOS ORNATUS) WITH ALOPECIA SYNDROME USING OCLACITINIB MALEATE (APOQUEL®).
Drake GJ; Nuttall T; López J; Magnone W; Leclerc A; Potier R; Lécu A; Guézénec M; Kolter L; Nicolau A; Lemberger K; Pin D; Cosgrove SB
J Zoo Wildl Med; 2017 Sep; 48(3):818-828. PubMed ID: 28920784
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and pharmacodynamics of tramadol in horses following oral administration.
Knych HK; Corado CR; McKemie DS; Scholtz E; Sams R
J Vet Pharmacol Ther; 2013 Aug; 36(4):389-98. PubMed ID: 23061925
[TBL] [Abstract][Full Text] [Related]
16. Plasma pharmacokinetics of ranitidine HCl in adult horses.
Holland PS; Ruoff WW; Brumbaugh GW; Brown SA
J Vet Pharmacol Ther; 1997 Apr; 20(2):145-52. PubMed ID: 9131542
[TBL] [Abstract][Full Text] [Related]
17. A blinded, randomized, placebo-controlled trial of the safety of oclacitinib in cats.
Lopes NL; Campos DR; Machado MA; Alves MSR; de Souza MSG; da Veiga CCP; Merlo A; Scott FB; Fernandes JI
BMC Vet Res; 2019 May; 15(1):137. PubMed ID: 31068210
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of single-dose and multiple-dose memantine in healthy chinese volunteers using an analytic method of liquid chromatography-tandem mass spectrometry.
Liu MY; Meng SN; Wu HZ; Wang S; Wei MJ
Clin Ther; 2008 Apr; 30(4):641-53. PubMed ID: 18498913
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and safety of repeated oral dosing of acetaminophen in adult horses.
Mercer MA; McKenzie HC; Davis JL; Wilson KE; Hodgson DR; Cecere TE; McIntosh BJ
Equine Vet J; 2020 Jan; 52(1):120-125. PubMed ID: 30900298
[TBL] [Abstract][Full Text] [Related]
20. Oclacitinib (APOQUEL®) is a selective Janus kinase 1 inhibitor with efficacy in a canine model of flea allergic dermatitis.
Gonzales AJ; Aleo M; Mahabir S; Messamore J; Stegemann M
J Vet Pharmacol Ther; 2024 Jun; ():. PubMed ID: 38926932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
